Is rapid preparation for thyroidectomy in severe Graves’ disease beneficial? The relationship between clinical and immunohistochemical aspects
Authors:
- 1 April 2008
- journal article
- Published by Springer Nature in Endocrine
- Vol. 33 (2) , 189-195
Abstract
Background To evaluate the effect of Lugol’s Iodine (LI) on angiogenic characteristics and postthyroidectomy morbidity in patients with Graves’ Disease (GD). Methods Medical records of 153 patients, who underwent thyroidectomies for GD between 1987 and 2006 were reviewed. LI in addition to antithyroid drugs (ATD) was administered to 16 toxic Graves’ cases (group I), while 137 received ATD only (group II). In order to evaluate thyroid vascularity, immunohistochemical staining (IHS) for VEGF and CD31 for assessing microvessel density (MVD) were performed in group I, 20 random cases of group II, and 7 stochastic patients with non-toxic goiter (group III). Results Early postoperative complications were significantly higher in group I compared to group II: (transient recurrent nerve palsy (P < 0.04), transient hypocalcemia (P < 0.02), and postoperative bleeding (P < 0.003)). Meanwhile permanent complications were not significantly different. VEGF-IHS revealed ten patients of group I (62.5%) to have positive staining compared to only 3 (15%) of group II. All patients of group III stained positive. The expression of VEGF was more intense in group I as compared to group II (P < 0.02). However, no significant difference of MVD among all groups was recorded. Conclusion Preoperative LI treatment may be associated with increased early postoperative morbidity and did not affect thyroid vascularity.Keywords
This publication has 29 references indexed in Scilit:
- Significance of thyroid blood flow as a predictor of methimazole sensitivity in untreated hyperthyroid patients with Graves' diseaseBiomedicine & Pharmacotherapy, 2007
- Iodide Inhibits Vascular Endothelial Growth Factor-A Expression in Cultured Human Thyroid Follicles: A Microarray Search for Effects of Thyrotropin and Iodide on Angiogenesis FactorsThyroid®, 2006
- A systematic review of drug therapy for Graves’ hyperthyroidismEuropean Journal of Endocrinology, 2005
- Expression of vascular endothelial growth factor (VEGF) and VEGF receptor-1 (Flt-1) in Graves disease possibly correlated with increased vascular densityHuman Pathology, 2001
- Graves' DiseaseNew England Journal of Medicine, 2000
- Increased Serum Vascular Endothelial Growth Factor Levels and Intrathyroidal Vascular Area in Patients with Graves’ Disease and Hashimoto’s ThyroiditisThe Journal of Clinical Endocrinology & Metabolism, 1998
- Mechanisms of angiogenesisNature, 1997
- Retrospective evaluation of subtotal and total thyroidectomy in Graves' disease with and without endocrine ophthalmopathyEuropean Journal of Endocrinology, 1995
- Tumor angiogenesis in breast cancer: Its importance as a prognostic indicator and the association with vascular endothelial growth factor expressionBreast Cancer Research and Treatment, 1995
- Effect of Lugolʼs iodine on the vascularity of thyroid gland in hyperthyroidismNuclear Medicine Communications, 1989